Low Dose Naltrexone (LDN)

Low Dose Naltrexone (LDN) is emerging as a promising new off-label treatment for management of symptoms from autoimmune diseases, central nervous system disorders, and even certain cancers. Naltrexone 50 MG tablet was approved by the FDA for the treatment of opioid addiction by acting as a competitive opioid receptor antagonist and blocking the effects of opioids on the brain. 

LDN refers to daily doses of Naltrexone that are within 1to 5 mg--a tenth of the typical FDA-approved treatment dosage.  Studies have shown that naltrexone exhibits paradoxical properties such as analgesia and anti-inflammatory, or antioxidant effects via upregulation of endogenous opioids at low doeses. 

 

What diseases are impacted by LDN? 

Side Effects

One of the most exciting aspects of LDN is the low reported incidence of adverse side effects.  Studies have shown no withdrawal symptoms when treatment is stopped due to its low dosage.  In some cases, patients may report vivid dreams, nausea, or headaches.  However, these decrease over time or dosage can be decreased if needed.  

If you would like to meet with the Dr. and talk about your options please give us a call at 503-286-4400

Author
Rise2Health Staff

You Might Also Enjoy...

WAYS TO ILLIMINATE STRESS

Are you tired? Do you feel stressed? Did you know that stress disrupts nearly all of the systems in your body?! It also can significantly lower your immune system, leaving you more susceptible to illness.